Jaguar Health (Nasdaq: JAGX) is a commercial-stage pharmaceutical company focused on developing and commercializing plant-based prescription medicines for gastrointestinal conditions and supportive care. The company’s portfolio includes therapies designed to address unmet medical needs in both human and animal health markets.

Topics discussed include the company’s commercial portfolio, business strategy, growth initiatives, market opportunities, and long-term outlook.

This company webcast was recorded during the Lytham Partners Spring 2026 Investor Conference.